| Previous Close | 0.647 |
| Open | 0.650 |
| Bid | 0.710 x 3100 |
| Ask | 0.720 x 3000 |
| Day's Range | 0.650 - 0.738 |
| 52 Week Range | 0.390 - 8.810 |
| Volume | 1,262,738 |
| Avg. Volume | 569,539 |
| Market Cap | 35.11M |
| Beta | 0.35 |
| PE Ratio (TTM) | -0.25 |
| EPS (TTM) | -2.8 |
| Earnings Date | Oct 30, 2017 - Nov 3, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.88 |
- Thomson Reuters StreetEvents•7 days ago
Edited Transcript of TNDM earnings conference call or presentation 27-Jul-17 8:30pm GMT
Q2 2017 Tandem Diabetes Care Inc Earnings Call
- Business Wire•7 days ago
Tandem Diabetes Care Begins Enrollment in Pivotal Trial for First Touchscreen Insulin Pump with Predictive Low Glucose Suspend (PLGS)
Tandem Diabetes Care®, Inc. , a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced enrollment of the first patients in an at-home pivotal trial for its t:slim X2™ Insulin Pump using Tandem’s predictive low glucose suspend technology.
- ACCESSWIRE•7 days ago
Today's Research Reports on Trending Tickers: AVEO Pharmaceuticals Inc. and Tandem Diabetes Care Inc.
NEW YORK, NY / ACCESSWIRE / August 15, 2017 / U.S. markets rebounded sharply Monday as geopolitical tensions eased after Secretary of State Rex Tillerson and U.S. Secretary of Defense James Mattis commented ...
